A randomized trial of conjugated group B streptococcal type Ia vaccine in a rabbit model of ascending infection

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 4, 1999, Pages 803-808

  Davies, Jill K ^a   Paoletti, Lawrence C ^a   McDuffie, Robert S ^a   Madoff, Lawrence C ^a   Lee, Scott ^a   Eskens, Joan ^a   Gibbs, Ronald S ^a  

^a NONE

Author keywords

Group B Streptococcus; Intra amniotic infection; Neonatal sepsis; Rabbit; Vaccination

Indexed keywords

IMMUNOGLOBULIN G; POLYSACCHARIDE VACCINE; STREPTOCOCCUS VACCINE; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONCEPTION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG CONJUGATION; FEMALE; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROGENY; RABBIT; RANDOMIZATION; SEPSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VACCINATION;

EID: 0032741630     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70305-4     Document Type: Conference Paper

References (12)

1. 1. Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976;294:753-6.
2. 2. Anonymous, Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Morb Mortal Wkly Rep 1996;45:1-24.
3. 3. Piper J, Wen T, Peairs W. Group B Strep resistance to antibiotics and peripartum outcomes [abstract]. Am J Obstet Gynecol 1999;180:S84.
4. 4. Baker CJ, Paoletti LC, Wessels MR, Guttormsen HK, Reneli MA, Hickman ME, et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999;179:142-50.
5. 5. Rodewald AK, Onderdonk AB, Warren HB, Kasper DL. Neonatal mouse model of group B streptococcal infection. J Infect Dis 1992;166:635-9.
6. 6. Wessels MR, Paoletti LC, Rodewald AK, Michon F, DiFabio J, Jennings HJ, et al. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1993;61: 4760-6.
7. 7. Wessels MR, Paoletti LC, Kasper DL, DiFabio JL, Michon F, Holme K, et al. Immunogenicity in animals of a polysaccharide-protein conjugated vaccine against type III group B streptococcus. J Clin Invest 1990;86:1428-33.
8. 8. McDuffie RS, Gibbs RS. Ascending group B streptococcal genital infection in the rabbit model. Am J Obstet Gynecol 1996;175:402-5.
9. 9. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC Jr. Color atlas and textbook of diagnostic microbiology. 5th ed. Philadelphia: Lippincott; 1997.
10. 10. Paoletti LC, Wessels MR, Rodewald AK, Shroff AA, Jennings HJ, Kasper DL. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun 1994;62:3236-43.
11. 11. Larsen JW Jr, Harper JS III, London WT, Baker CJ, Curfman BL, Kasper DL, et al. Antibody to type III group B Streptococcus in the rhesus monkey. Am J Obstet Gynecol 1983;146:958-62.
12. 12. Wessels MR, Kasper DL, Johnson KD, Harrison LH. Antibody responses in invasive group B streptococcal infection in adults. J Infect Dis 1998;178:569-72.